BMY vs KWR · P/E 17, rev $24.46B vs P/E 592, rev $1.01B
Bristol-Myers Squibb Company (BMY) versus Quaker Chemical Corporation (KWR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Quaker Chemical Corporation (KWR) is a specialty chemicals company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported KWR revenue for 2026-06-30 was $1.01B. Net income was $46.5M. KWR currently screens at market cap $2.57B and trailing P/E 592.4.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. KWR currently screens at market cap $2.57B and trailing P/E 592.4.
Not investment advice. Open the BMY and KWR stock pages for the full models.
Not investment advice.